
Patrik Jonsson, executive vice president and president, Lilly International, will retire at the end of 2026

Treatment with Olumiant resulted in substantial scalp hair regrowth, as well as improvements in eyebrows and eyelashes

The deal focuses on addressing critical unmet medical needs

The updated vaccine will be available to eligible groups as part of the 2026/27 NHS vaccination programme

The 2026-2027 vaccine targets the XFG variant to more closely match current variants

The acquisition is to advance treatments for serious autoimmune and allergic diseases

The UK is the first country in Europe to authorise the oral medication

Around 60,000 people in the US get pancreatic cancer each year, with an estimated 50,000 deaths projected annually

The acquisition will advance therapies for treatment-resistant depression and other mental health conditions

This new option for patients allows for as few as six maintenance injections per year

The acquisitions reinforce the company’s commitment to reduce the long-term burden of serious disease

Six-year initiative to improve NCD prevention and care for children in low- and middle-income countries